Lincoln Pharmaceuticals Limited (BOM:531633)
622.00
+3.60 (0.58%)
At close: Mar 4, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 12.49 billion as of March 5, 2026. Its market cap has decreased by -8.40% in one year.
Market Cap
12.49B
Enterprise Value
10.17B
Revenue
6.52B
Ranking
n/a
PE Ratio
14.22
Stock Price
622.00
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 12.49B, an increase of 8,888.55%. That is a compound annual growth rate of 23.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 12.46B | 28.73% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shukra Pharmaceuticals | 18.91B |
| Amrutanjan Health Care | 16.47B |
| Kwality Pharmaceuticals | 15.70B |
| TTK Healthcare | 12.21B |
| Syncom Formulations (India) | 11.36B |
| Fermenta Biotech | 9.56B |
| Venus Remedies | 9.37B |
| Wanbury | 8.72B |